Exclusive: SoundHealth raises $12.25M to commercialize its nasal wearable

Exclusive: SoundHealth raises $12.25M to commercialize its nasal wearable

SoundHealth, which makes a wearable device for sinus congestion, raised a $12.25 million Series A, CEO Paramesh Gopi tells Axios Pro exclusively.

The big picture: Medtech VC funding has grown increasingly selective, favoring later-stage companies with clearer clinical and commercial paths.

How it works: The San Francisco-based company makes an FDA-approved, non-invasive device for nasal congestion and sleep problems.

  • Its wearable headband uses acoustic resonance to stimulate the sinuses. Treatment settings are personalized through a smartphone scan of the user's craniofacial anatomy.
  • Gopi says the company's FDA clearance data showed improvements in nasal congestion and rhinitis symptoms.

    • Follow the money: ShangBay Capital led the Series A, which SoundHealth plans to use to expand commercialization and increase adoption.

  • The company is focused on growing adoption among ENTs, allergists, primary care doctors, and dental and craniofacial specialists.
  • "Our biggest scale challenge is education across specialties," Gopi says.

    • Zoom out: Medical device manufacturers are incorporating AI into products at a growing rate, expanding beyond administrative and engagement tasks.

  • One market estimate predicts AI sleep tech will nearly double from $3.92 billion in 2026 to $7.73 billion by 2030.

    • What's next: Gopi says the company also plans to pursue additional indications in 2027, including mental health conditions.